IP Library Granted Patent US 11,571,405
Granted Patent B2
US 11,571,405 · App. 17/504,255 · Granted Feb 7, 2023

Compositions for improving sexual function

Inventors: Djamaluddin Zaferan (Copenhagen, DK); Jahangir Khan (Copenhagen, DK)
Assignee: INXO A/S
A61K31/198A61K31/352A61P15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,571,405
App. No.
17/504,255
Granted
Feb 7, 2023
Kind
B2
Abstract

Compositions comprising L-arginine and L-citrulline in specific ratios are provided. Use of such compositions for improving sexual function in a healthy human subject are also provided.

Claims (3)

1. A composition comprising L-arginine and L-citrulline or a physiologically acceptable salt or hydrate of any one thereof, wherein the composition is in a unit dosage form and wherein the content of L-arginine or a physiologically acceptable salt or hydrate thereof is at least 4.0 g and the content of L-citrulline or a physiologically acceptable salt or hydrate thereof is in the range from 1.1-3.0 g, wherein the composition comprises one or more proanthocyanidins.

2. A composition according to claim 1 , wherein the content of L-arginine or a physiologically acceptable salt or hydrate thereof is in the range of from 4.0-10.0 g.

3. A composition according to claim 1 , wherein the composition is in a unit dosage form for use on demand.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2022
From: ZAFERAN, DJAMALUDDIN; KHAN, JAHANGIR
To: INXO IVS
Reel/Frame 060842/0104 →
CHANGE OF NAME Recorded Oct 18, 2021
From: INXO IVS
To: INXO APS
Reel/Frame 057876/0314 →
CHANGE OF NAME Recorded Oct 18, 2021
From: INXO APS
To: INXO A/S
Reel/Frame 057876/0325 →
Priority Claims (1)
DK PA 2018 70801 · Dec 7, 2018 · national
Continuity (3)
Division 17056290 · Nov 17, 2020
Continuation In Part 16706087
Related Publication 20220040132A1 · Feb 10, 2022